Companies / Oric Pharmaceuticals, Inc.

Oric Pharmaceuticals, Inc.

Nasdaq: ORICCIK 1796280SOUTH SAN FRANCISCO, CA

Financials

Revenue—
Net income$-129.47M
Total debt$10.50M
Cash$37.48M
Diluted EPS$-1.47
Shares outstanding103.7M

Ownership

103.7M shares outstanding · as of Jul 27, 2026
0.31%Insiders
Ownership
Insiders0.31%323,020
10%+ / strategic5.28%5,473,145
Institutions110.24%114,268,951
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Heyman Richard A.Director
0.25%254,872
Piscitelli DominicChief Financial Officer
0.07%68,148
Chacko JacobCEOPRESIDENT AND CEO · Director
——
Dier MardiDirector
——
Hoerter Steven L.Director
——
Kunkel Lori AnneDirector
——
Multani Pratik SChief Medical Officer
——
You AngieDirector
——

Institutional holders 175

View all →
HolderValue% of shares
BlackRock, Inc.$73.90M6.58%
Viking Global Investors LP$73.80M5.62%
Nextech Invest, Ltd.$58.59M6.91%
Alkeon Capital Management LLC$57.07M4.35%
EcoR1 Capital, LLC$55.04M6.49%
State Street Corporation$53.00M4.72%
VR Adviser, LLC$46.43M5.48%
Pfizer Inc$43.98M5.19%
Sr One Capital Management, LP$37.75M4.36%
Vanguard Group Inc$37.15M4.38%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 24, 2026Piscitelli Dominic
Executive
SellCommon Stock$702.7K-52K
-43.28%
68,148
0.07% of shares
medium
Feb 24, 2026Piscitelli Dominic
Executive
ExerciseCommon Stock$226.7K+52K
+76.30%
120,148
0.12% of shares
low
Jan 16, 2026Heyman Richard A.
Director
SellCommon Stock$42.0K-4K
-7.73%
41,800
0.04% of shares
low
Jan 16, 2026Heyman Richard A.
Director
SellCommon Stock$38.4K-3K
-1.48%
213,072
0.21% of shares
low
Feb 24, 2026Piscitelli Dominic
Executive
ExerciseStock Option (right to buy)—-52K
-26.46%
144,500
0.14% of shares
low
Jan 2, 2026Piscitelli Dominic
Executive
GrantRestricted Stock Unit—+35K
34,500
0.03% of shares
low
Jan 2, 2026Piscitelli Dominic
Executive
GrantStock Option (right to buy)—+207K
206,500
0.20% of shares
low
Jan 2, 2026You Angie
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Venrock Healthcare Capital Partners III, L.P.Passive13G/A———
BlackRock, Inc.Passive13G—5,473,145—
Viking Global Investors LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ORIC——68622P109—